Biocon

Lancet Citizens’ Commission on Reimagining India’s Health System Launched

The Covid-19 pandemic and response are having profound impacts on India’s people, leading to myriad health-care challenges, a looming economic recession, and humanitarian crises. The Lancet on Friday launched the…

View Post

Spotlight

Health Ministry Decides Against Including Itolizumab In Clinical Management Protocols For COVID-19

The National Task Force on COVID-19 has decided against including Itolizumab drug in clinical management protocols for treating the disease. Biocon’s Itolizumab is an approved drug which is used for…

View Post

Latest News

Itolizumab Gets Approval For Use In Moderate To Severe COVID-19 Patients

Drugs Controller General of India’s (DCGI) has given its nod to Biotechnology major Biocon to use its “breakthrough drug,” Itolizumab in moderate to severe COVID-19 patients. India’s drug regulator has…

View Post

Latest News

Biocon Ties Up With DKSH For Distribution Of Seven Products In Singapore, Thailand

Biocon has signed an agreement with market expansion services provider DKSH for distribution of seven generic products in Singapore and Thailand. Biocon Pharma Ltd, a subsidiary of the bio-tech firm,…

View Post

Latest News

Biocon Announces The Launch Of Fulphila In Australia

Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia. Fulphila is approved by the Therapeutic Goods Administration for the…

View Post

Latest News

Biocon’s Manufacturing Facility In Malaysia Receives Establishment EIR From USFDA

Biocon Ltd on Wednesday said its insulin manufacturing facility in Malaysia has received Establishment Inspection Report (EIR) from the US health regulator with a ‘Voluntary Action Indicated’ classification. In a…

View Post

Latest News

Biocon, Mylan Win US Court Ruling In Favour Of Insulin Glargine

Biotechnology firm Biocon on Wednesday said a US court has invalidated a Sanofi patent on the insulin glargine device. It will now remove a key legal hurdle to commercialising Semglee…

View Post

Menu

Biocon

Lancet Citizens’ Commission on Reimagining India’s Health System Launched

Health Ministry Decides Against Including Itolizumab In Clinical Management Protocols For COVID-19

Itolizumab Gets Approval For Use In Moderate To Severe COVID-19 Patients

Biocon Ties Up With DKSH For Distribution Of Seven Products In Singapore, Thailand

Biocon Announces The Launch Of Fulphila In Australia

Biocon’s Manufacturing Facility In Malaysia Receives Establishment EIR From USFDA

Biocon, Mylan Win US Court Ruling In Favour Of Insulin Glargine

Winter Heart Attack Alert: 8 Doctor-Approved Lifestyle Changes for Better Cardiovascular Health

Sea Level Set to Rise 1 Metre by 2100, Threatening 14 Million in Coastal Regions: Study Warns

Not Just Smog, Surge in ‘Walking Pneumonia’ Cases Alarms Delhi Residents

Man Declared Dead In Rajasthan Hospital Found Alive Before Last Rites; 4 Doctors Suspended

Breathlessness and Persistent Coughing: Early Signs of a Progressive Lung Disease, Experts Warn

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking

Diabetes Treatment Breakthrough: Canagliflozin Improves Kidney Oxygenation, Shows Study

AIIMS Discovers New Drug Combo to Control Hypertension More Effectively